ArticleCPT: pharmacometrics & systems pharmacology2023

Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.

Chaitali Passey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.